U.S. FDA authorizes use of S. Korean COVID-19 test kit Allplex
- 4 years ago
씨젠 "코로나19 진단키트, 미국 FDA 긴급사용 승인"
The South Korean biotech company Seegene has received emergency use authorization from the U.S. Food and Drug Administration today for their latest COVID-19 test kit Allplex.
Seegene was one of five local companies whose kits earned emergency-use approval from the South Korean health authorities last month.
This kit uses the real-time polymerase chain reaction testing method, which screens for three target genes to determine whether someone's infected.
It gets a result in about six hours.
Similar kits are being used in around 60 countries around the world.
The South Korean biotech company Seegene has received emergency use authorization from the U.S. Food and Drug Administration today for their latest COVID-19 test kit Allplex.
Seegene was one of five local companies whose kits earned emergency-use approval from the South Korean health authorities last month.
This kit uses the real-time polymerase chain reaction testing method, which screens for three target genes to determine whether someone's infected.
It gets a result in about six hours.
Similar kits are being used in around 60 countries around the world.